Nano-robotic based Thrombolysis: Dissolving Blood Clots using Nanobots

TL;DR

This paper proposes using nanobots in the bloodstream to target and dissolve internal blood clots more efficiently, precisely, and less invasively than current methods.

Contribution

Introduction of nanobots as carriers for targeted thrombolysis, enabling access to deep and hard-to-reach blood clots within the body.

Findings

Nanobots can effectively reach deep blood clots.

Nanobots provide a less invasive treatment option.

Potential for increased precision in clot dissolution.

Abstract

Medicine has taken a big jump in its advancement in the past few years. With the introduction of technology and the synthesis of personalized medicines, doctors have been successful in treating even the deadliest of the diseases. Though surgeries, which have been flourishing with a good success rate in the past, have become feasible and they are being regularly performed to reach out for internal infected areas that cannot be treated from the outside, there still are areas in the body that are physically beyond the reach of a doctor. Internal blood clots are one such problem that has been prolonging for a very long time and sometimes can be located in certain areas that are too deep inside, which makes them virtually impossible to reach, deep arteries or veins, narrow internal sections of brain or lungs. In this paper, we propose an approach which puts Nano-robotics into use to deal with the problem of internal blood clots. This method looks at introducing swamps of nanobots in ones bloodstream which acts as carriers of medicines to the sites which are difficult to access for treatment physically. This will not just ease the process but it promises to be far more efficient, precise and less invasive than the currently existing techniques.